Granules India Ltd., announced financial results for its fourth quarter and financial year ended on March 31, 2018. The company’s standalone total income during the year was Rs. 1678 crore. In this…Read More
Strides Shasun has sought shareholders’ nod to change its name to Strides Pharma Science. This is the second time in 3 years, when the name of the company will change….Read More
Lupin’s marketing authorization application (MAA) for a biosimilar of Etanercept has been accepted for review by the European Medicines Agency (EMA). The indications targeted for approval are rheumatoid arthritis (RA),…Read More
Suven Life Sciences Ltd have received the grant of one product patent from China (CN105814020) and one product patent from USA (9957257) corresponding to the new chemical entities (NCEs) for…Read More
Cipla is looking for a billion-dollar consolidated revenue for the domestic market in FY19. The company reported revenues of Rs. 15,219 crore, growing 6 percent, with income from the India operations…Read More
Sun Pharmaceutical Industries Ltd. reported financials for the fourth quarter and full year ending March 31, 2018. Highlights of Q4FY18 consolidated financials: Sales/income from operations at Rs. 6711 crore, de-growth of…Read More
Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, and Helsinn Group, a Swiss pharmaceutical group focused on building quality cancer care products, have entered into an exclusive licensing agreement…Read More
Strides Shasun Limited’s wholly owned subsidiary Strides Pharma Global Pte. Ltd. has received approval for Cyproheptadine Hydrochloride Tablets USP, 4 mg from the United States Food and Drug Administration (USFDA)….Read More
Cipla has launched an authorized generic version of Aloxi in the United States of America under applicable agreements with Helsinn Healthcare SA, in response to the at-risk launch by Teva….Read More
Pfizer Inc. and Allogene Therapeutics Inc. have entered into an asset contribution agreement for Pfizer’s portfolio of assets related to allogeneic chimeric antigen receptor T-cell (CAR-T) therapy, an investigational immune…Read More
Suven Life Sciences Ltd has been granted one product patent from Canada (2907620) corresponding to the new chemical entity (NCE) for the treatment of disorders associated with neurodegenerative diseases and…Read More
Zydus Cadila has received the final approval from the USFDA to market Metoprolol Succinate extended-release tablets USP in the strengths of 25 mg, 50 mg, 100 mg, and 200 mg….Read More
Pharma major Lupin has signed an agreement with CSIR-National Chemical Laboratory, Pune (CSIR-NCL) and Department of Science and Technology, Delhi (DST) for conducting research on a continuous purification process development…Read More
Recent Comments